|
Methylthioadenosine Phosphorylase and AdoMet Synthetase in Cancer
|
5R01CA135405-11
|
$290,592
|
|
SCHRAMM, VERN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Exploiting the immune response to detect pathogen-induced cancers
|
5R01CA199948-04
|
$492,377
|
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
5R01CA182901-04
|
$612,939
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Georgia CaRes
|
5UG1CA189851-05
|
$875,025
|
|
GHAMANDE, SHARAD
|
AUGUSTA UNIVERSITY
|
|
Role of heat shock transcription factor HSF1 in tumoroginesis
|
5R01CA062130-23
|
$556,510
|
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
Identification of clonal DNA methylation and chromatin accessibility
|
5R03CA212829-02
|
$76,000
|
|
SHI, HUIDONG
|
AUGUSTA UNIVERSITY
|
|
NCI Community Oncology Research Program (NCORP) - Community Sites
|
5UG1CA190140-05
|
$1,188,290
|
|
SAPHNER, THOMAS
|
AURORA HEALTH CARE, INC.
|
|
BCM Oncology Scholars Training Program
|
5T32CA174647-05
|
$258,995
|
|
LIN, WEEI-CHIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF
|
5R01CA193321-04
|
$362,569
|
|
MITSIADES, NICHOLAS
|
BAYLOR COLLEGE OF MEDICINE
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER
|
5R01CA181572-05
|
$319,735
|
|
GOEL, AJAY
|
BAYLOR RESEARCH INSTITUTE
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-03
|
$215,047
|
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
HDAC8 Mediated Regulation of Acute Myeloid Leukemia Pathogenesis and Maintenance
|
5R01CA178387-05
|
$317,475
|
|
KUO, YA-HUEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting microRNAs to eradicate leukemia stem cells
|
5R01CA205247-02
|
$450,769
|
|
KUO, YA-HUEI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
5R21CA205106-02
|
$176,605
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
FEN1-mediated Okazaki fragment maturation and its deficiency in cancer
|
5R01CA073764-22
|
$369,788
|
|
SHEN, BINGHUI
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Regulation of Ionizing Radiation-Induced DNA Damage Response
|
5R01CA130899-10
|
$382,500
|
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Molecular Mechanisms of BRCA1-Dependent DNA Damage Response and Tumorogenesis
|
5R01CA132755-11
|
$382,500
|
|
YU, XIAOCHUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
SOX9 Mediation of AR and ERG Driven Prostate Cancer
|
5R01CA168393-05
|
$361,050
|
|
BALK, STEVEN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of extracellular matrix mediated drug resistance
|
5R00CA180221-05
|
$248,999
|
|
MURANEN, TARU
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
(PQ7) In Vivo Cellular Optical Imaging of Esophageal Tumors and Microenvironment
|
5R01CA205431-03
|
$522,325
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Exploiting Metabolic Vulnerabilities in the PI3K and Akt Pathway in Cancer for Therapeutic Benefit
|
5R01CA200671-03
|
$395,738
|
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of m6A mRNA methylation in Neuroblastoma
|
5R21CA219352-02
|
$191,227
|
|
GREGORY, RICHARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Cancer Deep Phenotype Extraction from Electronic Medical Records
|
5U24CA184407-06
|
$993,015
|
|
SAVOVA, GUERGANA
|
BOSTON CHILDREN'S HOSPITAL
|
|
National Research Mentoring Network for a Diverse Biomedical Workforce
|
5U54GM119023-05
|
$487,159
|
|
PFUND, CHRISTINE
|
BOSTON COLLEGE
|
|
Role of c-Cbl in Colon cancer
|
5R01CA175382-05
|
$361,050
|
|
CHITALIA, VIPUL
|
BOSTON MEDICAL CENTER
|
|
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
|
5R01CA138509-10
|
$368,325
|
|
REINHARD, BJOERN
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Accelerating Cancer Genomics with Cloud-scale Bioconductor
|
5U01CA214846-02
|
$438,654
|
|
CAREY, VINCENT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The VITamin D and OmegA-3 TriaL (VITAL)
|
5R01CA138962-10
|
$3,474,603
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum
|
5R44CA192588-04
|
$234,573
|
|
YANG, DERSHUNG
|
BRIGHTOUTCOME INC.
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-03
|
$518,165
|
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
Breast Cancer Locator
|
5R44CA210810-04
|
$969,868
|
|
KRISHNASWAMY, VENKATARAMANAN
|
CAIRNSURGICAL, INC.
|
|
Determining the Epigenetic Mechanisms Driving Tissue Factor (F3) Upregulation and its Role in Metastatic Osteosarcoma
|
5F31CA213965-02
|
$44,524
|
|
BAYLES, IAN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanisms of metabolic reprogramming by PIK3CA oncogenic mutations
|
5R01CA196643-03
|
$383,725
|
|
WANG, ZHENGHE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
|
5R01CA218526-02
|
$384,283
|
|
DI VIZIO, DOLORES
|
CEDARS-SINAI MEDICAL CENTER
|
|
High resolution volumetric MRI for prostate cancer active surveillance
|
5R01CA217098-02
|
$379,039
|
|
KIM, HYUNG
|
CEDARS-SINAI MEDICAL CENTER
|
|
Nanoconjugate delivery of proliferation and checkpoint inhibitors to treat glial tumors
|
5R01CA206220-03
|
$547,857
|
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Protein-DNA Drug Carriers for Targeting Drug-Resistant Tumors
|
5R01CA129822-08
|
$374,063
|
|
MEDINA-KAUWE, LALI
|
CEDARS-SINAI MEDICAL CENTER
|
|
Rescuing Nucleic Acids from Formalin Damage in Cancer Specimens
|
5R44CA199142-03
|
$730,394
|
|
ORBAI, LUCIAN
|
CELL DATA SCIENCES, INC.
|
|
CIRI Oncology Research Alliance (CORA)
|
5UG1CA189809-05
|
$1,051,535
|
|
DEMING, RICHARD
|
CHI INSTITUTE FOR RESEARCH & INNOVATION
|
|
COG NCORP Research Base
|
5UG1CA189955-05
|
$3,037,489
|
|
POLLOCK, BRAD
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Improving risk allocation and developing novel therapies for children with T-ALL
|
5R01CA193776-04
|
$594,741
|
|
TEACHEY, DAVID
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Viral Modulation of Genetic Stability
|
5R01CA097093-15
|
$399,000
|
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Exosomes in tumor cell-mesenchymal stromal cell interaction
|
5R01CA207983-02
|
$449,691
|
|
DECLERCK, YVES
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Exploiting proteotoxic stress in therapy-refractory HER2+ breast cancers
|
5R01CA193549-04
|
$356,850
|
|
KOMUROV, KAKAJAN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Patient Preferences and Adherence in Adolescents and Young Adults with Cancer
|
5K07CA200668-03
|
$144,855
|
|
MCGRADY, MEGHAN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Novel mechanisms and therapeutic strategies of refractory leukemia
|
5F31CA217140-02
|
$37,204
|
|
MELGAR, KATELYN
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Targeting Cdc42 for bone marrow transplant therapies
|
5R01CA193350-04
|
$356,850
|
|
ZHENG, YI
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Microenvironment Interleukin-17 and Colorectal Cancer Treatment Resistance
|
5R01CA193359-04
|
$362,569
|
|
KALADY, MATTHEW
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Nanoparticle-mediated treatment for bone metastasis
|
5R01CA206189-03
|
$312,562
|
|
LABHASETWAR, VINOD
|
CLEVELAND CLINIC LERNER COM-CWRU
|
Total relevant funding to Interferon for this search: $4,542,084
|